6CEH image
Deposition Date 2018-02-11
Release Date 2018-05-23
Last Version Date 2023-10-04
Entry Detail
PDB ID:
6CEH
Keywords:
LYASE/LYASE INHIBITOR
Title:
Design, Synthesis, X-ray and Biological Activities of Selenides Bearing the Benzenesulfonamide Moiety as New Class of Agents for Prevention of Diabetic Cerebrovascular Pathology
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Escherichia coli
Method Details:
Experimental Method:
X-RAY DIFFRACTION
Resolution:
1.43 Å
R-Value Free:
0.20
R-Value Work:
0.15
R-Value Observed:
0.15
Space Group:
P 1 21 1
6CEH validation report
Macromolecular Entities
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Carbonic anhydrase 2
Gene (Uniprot):CA2
Chain IDs:A
Chain Length:259
Number of Molecules:1
Biological Source:Homo sapiens
UniProt ID:P00918 Pfam ID:PF00194 EC:4.2.1.1
Ligand Molecules
EZ1
GOL
SO4
ZN
Primary Citation
Design, Synthesis, and X-ray of Selenides as New Class of Agents for Prevention of Diabetic Cerebrovascular Pathology.
ACS Med Chem Lett 9 462 467 (2018)
PMID: 29795760 DOI: 10.1021/acsmedchemlett.8b00076

Abstact

A series of novel selenides bearing benzenesulfonamide moieties was synthesized and investigated for their inhibition on six human (h) carbonic anhydrase (CA, EC 4.2.1.1) isoforms such as the physiologically relevant hCA I, II, VA, VB, VII, and IX and the X-ray complex in adduct with hCA II for some of them investigated. These enzymes are involved in a variety of diseases including glaucoma, retinitis pigmentosa, epilepsy, arthritis, metabolic disorders, and cancer. The investigated compounds showed potent inhibitory action against hCA VA, VII, and IX, in the low nanomolar range, thus making them of interest for the development of isoform-selective inhibitors and as candidates for various biomedical applications.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
6CEH